Share Price and Basic Stock Data
Last Updated: November 28, 2025, 9:47 am
| PEG Ratio | 0.31 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ugro Capital Ltd operates within the Finance & Investments sector, focusing primarily on providing credit solutions to small and medium enterprises (SMEs). The company’s share price stood at ₹180 with a market capitalization of ₹2,539 Cr. Revenue has demonstrated a robust growth trajectory, soaring from ₹312 Cr in Mar 2022 to ₹1,396 Cr in Mar 2025, reflecting a compound annual growth rate (CAGR) indicative of strong operational performance. For the latest quarter ending Sep 2023, revenue recorded an impressive ₹245 Cr, marking a 17.2% increase from the previous quarter. This upward trend continued with revenue further rising to ₹268 Cr in Dec 2023. The company’s ability to consistently increase its income streams is crucial, especially in a competitive lending environment, as it positions itself to capitalize on the growing demand for SME financing in India.
Profitability and Efficiency Metrics
Ugro Capital’s profitability metrics exhibit a promising outlook, with a reported net profit of ₹156 Cr and a return on equity (ROE) of 8.26%. The company’s profit before tax for the trailing twelve months was ₹219 Cr, translating to a net profit margin of 10.31%, which is relatively competitive compared to industry norms. Over the past few quarters, net profit has shown a positive trend, increasing from ₹14 Cr in Mar 2023 to ₹41 Cr in Mar 2025. The interest coverage ratio (ICR) stood at 1.40x, indicating sufficient earnings to cover interest obligations, while financing margins have fluctuated, reaching a peak of 18% in Jun 2023. However, the gross non-performing asset (NPA) ratio has risen slightly to 2.00% in Dec 2023, which could indicate mounting pressure on asset quality, a key area of concern for financial institutions.
Balance Sheet Strength and Financial Ratios
Ugro Capital’s balance sheet reflects a healthy capital structure, with total assets reported at ₹9,168 Cr and reserves amounting to ₹1,954 Cr as of Mar 2025. The company has no long-term borrowings, although total borrowings have surged to ₹6,904 Cr, leading to a total debt-to-equity ratio of 3.37x, which is relatively high compared to typical sector ranges. The book value per share has increased significantly from ₹136.99 in Mar 2022 to ₹222.57 in Mar 2025, highlighting the company’s capital growth. Moreover, the enterprise value as of Mar 2025 was ₹7,869 Cr, reflecting a strong market position. Despite the high leverage, the interest coverage ratio remains adequate, suggesting that Ugro Capital can manage its debt obligations effectively, although maintaining asset quality will be critical as the company scales its operations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ugro Capital indicates a diversified ownership structure, with promoters holding 1.88% and foreign institutional investors (FIIs) owning 25.05% as of the latest reports. The public holds a significant 69.95% stake, reflecting robust retail investor interest. The proportion of FIIs has increased from 6.95% in Mar 2023 to 25.05% in Oct 2025, signaling growing confidence among institutional investors in Ugro’s growth prospects. Conversely, domestic institutional investors (DIIs) have seen a decline in their holdings, down to 1.34%. The total number of shareholders has increased significantly from 12,010 in Mar 2023 to 40,446 in Oct 2025, underscoring heightened interest in the company. This diverse ownership base may provide stability, although the declining DII stake could raise questions about institutional confidence in the long-term strategy.
Outlook, Risks, and Final Insight
Looking ahead, Ugro Capital is well-positioned to capitalize on the growing demand for SME financing in India, supported by its strong revenue growth and profitability metrics. However, the rising gross NPA ratio poses a risk to its asset quality, which could impact future profitability if not managed effectively. Additionally, the high debt-to-equity ratio may expose the company to interest rate fluctuations, requiring careful financial management. Ugro’s ability to sustain its growth trajectory while ensuring asset quality will be pivotal. If the company can navigate these challenges, it may continue to attract investor confidence and maintain its competitive edge in the financial services sector. On the other hand, failure to address asset quality concerns could hinder growth and erode investor trust.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ugro Capital Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Monarch Networth Capital Ltd | 2,441 Cr. | 308 | 484/280 | 15.7 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 35.2 Cr. | 0.50 | 2.42/0.46 | 4.87 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.96 Cr. | 10.0 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.8 Cr. | 48.4 | 72.0/47.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Naperol Investments Ltd | 466 Cr. | 810 | 1,433/772 | 48.4 | 2,055 | 1.10 % | 1.06 % | 0.95 % | 10.0 |
| Industry Average | 7,061.43 Cr | 1,444.02 | 75.87 | 3,872.22 | 0.35% | 21.83% | 14.30% | 7.26 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117 | 149 | 182 | 209 | 213 | 245 | 268 | 322 | 291 | 330 | 371 | 403 | 414 |
| Interest | 53 | 69 | 82 | 90 | 93 | 105 | 117 | 128 | 136 | 143 | 167 | 181 | 205 |
| Expenses | 57 | 64 | 81 | 87 | 82 | 99 | 107 | 136 | 113 | 139 | 152 | 161 | 156 |
| Financing Profit | 7 | 16 | 19 | 32 | 38 | 41 | 44 | 58 | 43 | 48 | 52 | 61 | 53 |
| Financing Margin % | 6% | 11% | 11% | 15% | 18% | 17% | 16% | 18% | 15% | 15% | 14% | 15% | 13% |
| Other Income | 5 | 6 | 8 | 8 | 5 | 9 | 12 | 8 | 10 | 13 | 14 | 9 | 8 |
| Depreciation | 2 | 5 | 5 | 6 | 8 | 9 | 9 | 10 | 10 | 11 | 12 | 13 | 13 |
| Profit before tax | 10 | 18 | 22 | 34 | 36 | 41 | 46 | 56 | 43 | 50 | 53 | 57 | 48 |
| Tax % | 29% | 70% | 41% | 58% | 29% | 29% | 30% | 42% | 29% | 29% | 29% | 29% | 29% |
| Net Profit | 7 | 5 | 13 | 14 | 25 | 29 | 33 | 33 | 30 | 36 | 38 | 41 | 34 |
| EPS in Rs | 0.82 | 0.59 | 1.47 | 1.57 | 2.16 | 2.47 | 2.78 | 2.78 | 2.58 | 3.02 | 3.18 | 3.44 | 2.92 |
| Gross NPA % | 1.70% | 1.70% | 1.70% | 2.46% | 1.80% | 1.90% | 2.00% | 2.00% | 2.00% | 2.10% | 2.10% | 2.30% | |
| Net NPA % | 1.20% | 1.20% | 1.10% | 1.31% | 1.00% | 1.10% | 1.10% | 1.10% | 1.20% | 1.30% | 1.50% | 1.60% |
Last Updated: August 20, 2025, 1:55 am
Below is a detailed analysis of the quarterly data for Ugro Capital Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Interest, as of Jun 2025, the value is 205.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Mar 2025) to 205.00 Cr., marking an increase of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 156.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 161.00 Cr. (Mar 2025) to 156.00 Cr., marking a decrease of 5.00 Cr..
- For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00%.
- For Net Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.92. The value appears to be declining and may need further review. It has decreased from 3.44 (Mar 2025) to 2.92, marking a decrease of 0.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 2 | 4 | 2 | 4 | 44 | 105 | 153 | 312 | 684 | 1,082 | 1,396 | 1,644 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 45 | 137 | 293 | 443 | 628 | 772 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 36 | 81 | 85 | 142 | 289 | 425 | 565 | 636 |
| Financing Profit | 5 | 2 | 3 | 2 | 3 | 7 | 11 | 24 | 33 | 101 | 214 | 204 | 235 |
| Financing Margin % | 86% | 76% | 92% | 86% | 91% | 16% | 10% | 16% | 10% | 15% | 20% | 15% | 14% |
| Other Income | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 46 | 37 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 12 | 12 | 18 | 35 | 46 | 53 |
| Profit before tax | 5 | 2 | 3 | 2 | 3 | 2 | 3 | 12 | 20 | 84 | 179 | 203 | 219 |
| Tax % | 30% | 7% | 14% | 2% | 8% | -155% | -488% | -137% | 28% | 53% | 33% | 29% | |
| Net Profit | 4 | 2 | 3 | 2 | 3 | 4 | 20 | 29 | 15 | 40 | 119 | 144 | 156 |
| EPS in Rs | 6.41 | 2.83 | 5.07 | 3.34 | 5.05 | 1.34 | 2.19 | 3.22 | 1.63 | 4.46 | 10.17 | 12.22 | 13.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 50.00% | -33.33% | 50.00% | 33.33% | 400.00% | 45.00% | -48.28% | 166.67% | 197.50% | 21.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -83.33% | 83.33% | -16.67% | 366.67% | -355.00% | -93.28% | 214.94% | 30.83% | -176.49% |
Ugro Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 89% |
| 5 Years: | 68% |
| 3 Years: | 65% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 49% |
| 3 Years: | 115% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 14% |
| 3 Years: | -2% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: May 13, 2025, 2:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 23 | 71 | 71 | 71 | 69 | 92 | 92 |
| Reserves | 23 | 25 | 27 | 29 | 32 | 796 | 851 | 882 | 896 | 915 | 1,347 | 1,954 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 24 | 255 | 766 | 1,802 | 3,149 | 4,653 | 6,904 |
| Other Liabilities | 1 | 0 | 0 | 0 | 0 | 26 | 36 | 37 | 86 | 173 | 188 | 218 |
| Total Liabilities | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 20 | 38 | 36 | 56 | 85 | 130 | 168 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 4 | 6 | 14 | 0 | 0 |
| Investments | 26 | 15 | 25 | 26 | 36 | 107 | 73 | 55 | 69 | 60 | 59 | 103 |
| Other Assets | 3 | 14 | 8 | 8 | 1 | 731 | 1,101 | 1,659 | 2,724 | 4,146 | 6,091 | 8,897 |
| Total Assets | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 |
Below is a detailed analysis of the balance sheet data for Ugro Capital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 92.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 92.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,954.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,347.00 Cr. (Mar 2024) to 1,954.00 Cr., marking an increase of 607.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 218.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 188.00 Cr. (Mar 2024) to 218.00 Cr., marking an increase of 30.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 9,168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,280.00 Cr. (Mar 2024) to 9,168.00 Cr., marking an increase of 2,888.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 38.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 103.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 103.00 Cr., marking an increase of 44.00 Cr..
- For Other Assets, as of Mar 2025, the value is 8,897.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,091.00 Cr. (Mar 2024) to 8,897.00 Cr., marking an increase of 2,806.00 Cr..
- For Total Assets, as of Mar 2025, the value is 9,168.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,280.00 Cr. (Mar 2024) to 9,168.00 Cr., marking an increase of 2,888.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 12.00 | -174.00 | -681.00 | 141.00 | 286.00 | 421.00 | 559.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 15% | 6% | 10% | 6% | 8% | 1% | 2% | 3% | 2% | 4% | 10% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.68 | 13.39 | 5.69 | 2.06 | 4.07 |
| Diluted EPS (Rs.) | 14.71 | 13.20 | 5.66 | 2.05 | 4.07 |
| Cash EPS (Rs.) | 20.70 | 16.89 | 8.28 | 3.81 | 5.74 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Revenue From Operations / Share (Rs.) | 151.82 | 114.42 | 94.70 | 43.55 | 21.24 |
| PBDIT / Share (Rs.) | 95.41 | 71.73 | 56.94 | 24.08 | 9.70 |
| PBIT / Share (Rs.) | 90.37 | 67.88 | 54.40 | 22.33 | 8.04 |
| PBT / Share (Rs.) | 22.09 | 19.52 | 12.09 | 2.86 | 1.72 |
| Net Profit / Share (Rs.) | 15.65 | 13.03 | 5.74 | 2.06 | 4.07 |
| PBDIT Margin (%) | 62.84 | 62.69 | 60.13 | 55.29 | 45.67 |
| PBIT Margin (%) | 59.52 | 59.32 | 57.44 | 51.27 | 37.84 |
| PBT Margin (%) | 14.55 | 17.05 | 12.76 | 6.56 | 8.09 |
| Net Profit Margin (%) | 10.31 | 11.38 | 6.05 | 4.73 | 19.17 |
| Return on Networth / Equity (%) | 7.03 | 8.29 | 4.04 | 1.50 | 3.01 |
| Return on Capital Employeed (%) | 38.12 | 20.96 | 17.06 | 9.25 | 4.50 |
| Return On Assets (%) | 1.56 | 1.90 | 0.92 | 0.50 | 1.64 |
| Long Term Debt / Equity (X) | 0.00 | 0.99 | 1.16 | 0.72 | 0.31 |
| Total Debt / Equity (X) | 3.37 | 3.24 | 3.20 | 1.86 | 0.80 |
| Asset Turnover Ratio (%) | 0.18 | 0.19 | 0.18 | 0.13 | 0.10 |
| Current Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Quick Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Interest Coverage Ratio (X) | 1.40 | 1.48 | 1.35 | 1.24 | 1.54 |
| Interest Coverage Ratio (Post Tax) (X) | 1.23 | 1.27 | 1.14 | 1.11 | 1.64 |
| Enterprise Value (Cr.) | 7869.00 | 6209.26 | 3942.28 | 2792.18 | 1301.28 |
| EV / Net Operating Revenue (X) | 5.64 | 5.92 | 6.01 | 9.09 | 8.69 |
| EV / EBITDA (X) | 8.97 | 9.45 | 9.99 | 16.43 | 19.02 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| Price / BV (X) | 0.73 | 1.40 | 1.02 | 1.22 | 0.89 |
| Price / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| EarningsYield | 0.09 | 0.05 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Ugro Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has increased from 13.39 (Mar 24) to 15.68, marking an increase of 2.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.71. This value is within the healthy range. It has increased from 13.20 (Mar 24) to 14.71, marking an increase of 1.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 20.70. This value is within the healthy range. It has increased from 16.89 (Mar 24) to 20.70, marking an increase of 3.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.82. It has increased from 114.42 (Mar 24) to 151.82, marking an increase of 37.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 95.41. This value is within the healthy range. It has increased from 71.73 (Mar 24) to 95.41, marking an increase of 23.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 90.37. This value is within the healthy range. It has increased from 67.88 (Mar 24) to 90.37, marking an increase of 22.49.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.09. This value is within the healthy range. It has increased from 19.52 (Mar 24) to 22.09, marking an increase of 2.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.65. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 15.65, marking an increase of 2.62.
- For PBDIT Margin (%), as of Mar 25, the value is 62.84. This value is within the healthy range. It has increased from 62.69 (Mar 24) to 62.84, marking an increase of 0.15.
- For PBIT Margin (%), as of Mar 25, the value is 59.52. This value exceeds the healthy maximum of 20. It has increased from 59.32 (Mar 24) to 59.52, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 17.05 (Mar 24) to 14.55, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 10.31. This value exceeds the healthy maximum of 10. It has decreased from 11.38 (Mar 24) to 10.31, marking a decrease of 1.07.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 8.29 (Mar 24) to 7.03, marking a decrease of 1.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 38.12. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 38.12, marking an increase of 17.16.
- For Return On Assets (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has decreased from 1.90 (Mar 24) to 1.56, marking a decrease of 0.34.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.99 (Mar 24) to 0.00, marking a decrease of 0.99.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 1. It has increased from 3.24 (Mar 24) to 3.37, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 24) to 1.40, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 3. It has decreased from 1.27 (Mar 24) to 1.23, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,869.00. It has increased from 6,209.26 (Mar 24) to 7,869.00, marking an increase of 1,659.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.64. This value exceeds the healthy maximum of 3. It has decreased from 5.92 (Mar 24) to 5.64, marking a decrease of 0.28.
- For EV / EBITDA (X), as of Mar 25, the value is 8.97. This value is within the healthy range. It has decreased from 9.45 (Mar 24) to 8.97, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.73, marking a decrease of 0.67.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ugro Capital Ltd:
- Net Profit Margin: 10.31%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 38.12% (Industry Average ROCE: 21.83%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 14.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16 (Industry average Stock P/E: 75.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.31%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | Equinox Business Park, Mumbai Maharashtra 400070 | cs@ugrocapital.com http://www.ugrocapital.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Satyananda Mishra | Non Exe.Chairman&Ind.Director |
| Mr. Shachindra Nath | Vice Chairman & Mng.Director |
| Mr. Karuppasamy Singam | Independent Director |
| Ms. Tabassum Abdulla Inamdar | Independent Director |
| Mr. Karnam Sekar | Independent Director |
| Mr. Hemant Bhargava | Independent Director |
| Mr. Rajeev K Agarwal | Independent Director |
| Mr. Suresh Eshwara Prabhala | Non Exe. & Nominee Director |
| Mr. Rohit Goyal | Non Exe. & Nominee Director |
| Mr. Chetan Gupta | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Ugro Capital Ltd?
Ugro Capital Ltd's intrinsic value (as of 28 November 2025) is 227.55 which is 30.78% higher the current market price of 174.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,481 Cr. market cap, FY2025-2026 high/low of 255/142, reserves of ₹1,954 Cr, and liabilities of 9,168 Cr.
What is the Market Cap of Ugro Capital Ltd?
The Market Cap of Ugro Capital Ltd is 2,481 Cr..
What is the current Stock Price of Ugro Capital Ltd as on 28 November 2025?
The current stock price of Ugro Capital Ltd as on 28 November 2025 is 174.
What is the High / Low of Ugro Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ugro Capital Ltd stocks is 255/142.
What is the Stock P/E of Ugro Capital Ltd?
The Stock P/E of Ugro Capital Ltd is 16.0.
What is the Book Value of Ugro Capital Ltd?
The Book Value of Ugro Capital Ltd is 211.
What is the Dividend Yield of Ugro Capital Ltd?
The Dividend Yield of Ugro Capital Ltd is 0.00 %.
What is the ROCE of Ugro Capital Ltd?
The ROCE of Ugro Capital Ltd is 11.0 %.
What is the ROE of Ugro Capital Ltd?
The ROE of Ugro Capital Ltd is 8.26 %.
What is the Face Value of Ugro Capital Ltd?
The Face Value of Ugro Capital Ltd is 10.0.